Sharad V. Jaswandkar

Sharad V. Jaswandkar

Auto-generated profile, based on publicly available information

Sharad V. Jaswandkar

Department of Civil, Construction, and Environmental Engineering North Dakota State University Fargo North Dakota USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2022 in Materials Advances
Verified
Journal Article
Open access
PDF file
KKKalpana S Katti
Kalpana S Katti
HJHaneesh Jasuja
Haneesh Jasuja
SJSharad V. Jaswandkar
Sharad V. Jaswandkar
SMSibanwita Mohanty
Sibanwita Mohanty
DKDinesh Ramanath Katti
Dinesh Ramanath Katti
Clays have been used as early as 2500 BC in human civilization for medicinal purposes. The ease of availability, biocompatibility, and versatility of these unique charged 2D structures abundantly available in nature have enabled the extensive applications of clays in human history. Recent advances in the use of clays in nanostructures and as components of polymer clay nanocomposites have exponentially expanded the use of clays in medicine. This review covers the details of structures and biomedical applications of several common clays, including montmorillonite, LAPONITE®, kaolinite, and halloysite. Here we describe the applications of these clays in wound dressings as hemostatic agents in drug delivery of drugs for cancer and other diseases and tissue engineering. Also reviewed are recent experimental and modeling studies that elucidate the impact of clay structures on cellular processes and cell adhesion processes. Various mechanisms of clay-mediated bioactivity, including protein localization, modulation of cell adhesion, biomineralization, and the potential of clay nanoparticles to impact cell differentiation, are presented. We also review the current developments in understanding the impact of clays on cellular responses. This review also elucidates new emerging areas of use of nanoclays in osteogenesis and the development of in vitro models of bone metastasis of cancer.

17 March 2023 in Biofabrication
Verified
Journal Article
Open access
HJHaneesh Jasuja
Haneesh Jasuja
SJSharad V Jaswandkar
Sharad V Jaswandkar
DKDinesh Ramanath Katti
Dinesh Ramanath Katti
KKKalpana S Katti
Kalpana S Katti
Prostate cancer bone metastasis is the leading cause of cancer-related mortality in men in the United States, causing severe damage to skeletal tissue. The treatment of advanced-stage prostate cancer is always challenging due to limited drug treatment options, resulting in low survival rates. There is a scarcity of knowledge regarding the mechanisms associated with the effects of biomechanical cues by the interstitial fluid flow on prostate cancer cell growth and migration. We have designed a novel bioreactor system to demonstrate the impact of interstitial fluid flow on the migration of prostate cancer cells to the bone during extravasation. First, we demonstrated that a high flow rate induces apoptosis in PC3 cells via TGF-β1 mediated signaling; thus, physiological flow rate conditions are optimum for cell growth. Next, to understand the role of interstitial fluid flow in prostate cancer migration, we evaluated the migration rate of cells under static and dynamic conditions in the presence or absence of bone. We report that CXCR4 levels were not significantly changed under static and dynamic conditions, indicating that CXCR4 activation in PC3 cells is not influenced by flow conditions but by the bone, where CXCR4 levels were upregulated. The bone-upregulated CXCR4 levels led to increased MMP-9 levels resulting in a high migration rate in the presence of bone. In addition, upregulated levels of α v β 3 integrins under fluid flow conditions contributed to an overall increase in the migration rate of PC3 cells. Overall, this study demonstrates the potential role of interstitial fluid flow in prostate cancer invasion. Understanding the critical role of interstitial fluid flow in promoting prostate cancer cell progression will enhance current therapies for advanced-stage prostate cancer and provide improved treatment options for patients.

22 January 2021 in Biomacromolecules
Verified
Journal Article
Closed access
SJSharad V. Jaswandkar
Sharad V. Jaswandkar
HFH M Nasrullah Faisal
H M Nasrullah Faisal
KKKalpana S Katti
Kalpana S Katti
DKDinesh Ramanath Katti
Dinesh Ramanath Katti

24 January 2024 in Materialia
Verified
Journal Article
Closed access
KKKrishna Kundu
Krishna Kundu
HGHanmant K. Gaikwad
Hanmant K. Gaikwad
SJSharad V. Jaswandkar
Sharad V. Jaswandkar
PRPreetham Ravi
Preetham Ravi
PVParth Vyas
Parth Vyas
KKKalpana S Katti
Kalpana S Katti

11 September 2022 in Materialia
Verified
Journal Article
Closed access
KKKrishna Kundu
Krishna Kundu
SJSharad V. Jaswandkar
Sharad V. Jaswandkar
DKDinesh Ramanath Katti
Dinesh Ramanath Katti
KKKalpana S Katti
Kalpana S Katti

22 May 2023 in Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences
Verified
Journal Article
Closed access
HGHanmant K. Gaikwad
Hanmant K. Gaikwad
SJSharad V. Jaswandkar
Sharad V. Jaswandkar
KKKalpana S Katti
Kalpana S Katti
AHAmanda Haage
Amanda Haage
DKDinesh Ramanath Katti
Dinesh Ramanath Katti
Integrin, as a mechanotransducer, establishes the mechanical reciprocity between the extracellular matrix (ECM) and cells at integrin-mediated adhesion sites. This study used steered molecular dynamics (SMD) simulations to investigate the mechanical responses of integrin α v β 3 with and without 10th type III fibronectin (FnIII 10 ) binding for tensile, bending and torsional loading conditions. The ligand-binding integrin confirmed the integrin activation during equilibration and altered the integrin dynamics by changing the interface interaction between β-tail, hybrid and epidermal growth factor domains during initial tensile loading. The tensile deformation in integrin molecules indicated that fibronectin ligand binding modulates its mechanical responses in the folded and unfolded conformation states. The bending deformation responses of extended integrin models reveal the change in behaviour of integrin molecules in the presence of Mn 2+ ion and ligand based on the application of force in the folding and unfolding directions of integrin. Furthermore, these SMD simulation results were used to predict the mechanical properties of integrin underlying the mechanism of integrin-based adhesion. The evaluation of integrin mechanics provides new insights into understanding the mechanotransmission (force transmission) between cells and ECM and contributes to developing an accurate model for integrin-mediated adhesion. This article is part of a discussion meeting issue ‘Supercomputing simulations of advanced materials’.